Menu
GeneBe

SOX3

SRY-box transcription factor 3, the group of SRY-box transcription factors

Basic information

Region (hg38): X:140502984-140505069

Previous symbols: [ "PHP" ]

Links

ENSG00000134595NCBI:6658OMIM:313430HGNC:11199Uniprot:P41225AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • 46,XX sex reversal 3 (Definitive), mode of inheritance: XLD
  • intellectual disability, X-linked, with panhypopituitarism (Definitive), mode of inheritance: XLR
  • septooptic dysplasia (Supportive), mode of inheritance: AD
  • 46,XX sex reversal 1 (Supportive), mode of inheritance: AD
  • X-linked intellectual disability with isolated growth hormone deficiency (Supportive), mode of inheritance: XL
  • X-linked congenital generalized hypertrichosis (Supportive), mode of inheritance: XL
  • panhypopituitarism (Supportive), mode of inheritance: AR
  • panhypopituitarism, X-linked (Limited), mode of inheritance: XL
  • intellectual disability, X-linked, with panhypopituitarism (Limited), mode of inheritance: XL
  • 46,XX sex reversal 3 (Definitive), mode of inheritance: XL
  • intellectual disability, X-linked, with panhypopituitarism (Definitive), mode of inheritance: XL
  • panhypopituitarism, X-linked (Strong), mode of inheritance: XL
  • SOX3-related X-linked pituitary hormone deficiency with or without intellectual developmental disorder (Moderate), mode of inheritance: XL

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Intellectual developmental disorder, X-linked, with panyhypopituitarism; Panhypopituitarism, X-linkedXLEndocrineTreatment for endocrine deficiencies, including those resulting in neonatal electrolyte abnormalities, may be beneficialEndocrine; Musculoskeletal; Neurologic8826446; 9106538; 11031100; 12428212; 15800844; 16167084; 17400794; 21183788
Deletions/insertions involving SOX3 regulatory regions can result in 46,XX sex reversal 3 (XL) or Hypoparathyroidism, X-linked by a position effect (XL)

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SOX3 gene.

  • not provided (52 variants)
  • Inborn genetic diseases (21 variants)
  • not specified (15 variants)
  • Intellectual disability, X-linked, with panhypopituitarism (7 variants)
  • Panhypopituitarism, X-linked (2 variants)
  • History of neurodevelopmental disorder (2 variants)
  • Abnormal brain morphology (1 variants)
  • 7 conditions (1 variants)
  • SOX3-related condition (1 variants)
  • 19 conditions (1 variants)
  • Oligospermia;Abnormal sperm morphology;See cases (1 variants)
  • Intellectual disability (1 variants)
  • Panhypopituitarism, X-linked;Intellectual disability, X-linked, with panhypopituitarism (1 variants)
  • Intellectual disability, X-linked, with panhypopituitarism;Panhypopituitarism, X-linked (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SOX3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
11
clinvar
4
clinvar
16
missense
33
clinvar
5
clinvar
3
clinvar
41
nonsense
0
start loss
0
frameshift
0
inframe indel
4
clinvar
6
clinvar
10
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
1
Total 0 0 39 22 7

Variants in SOX3

This is a list of pathogenic ClinVar variants found in the SOX3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
X-140503715-G-A SOX3-related disorder Likely benign (Jan 18, 2022)3054816
X-140503764-C-A Premature ovarian insufficiency Uncertain significance (Jan 10, 2018)619049
X-140503796-C-T Intellectual disability, X-linked, with panhypopituitarism Uncertain significance (Feb 06, 2023)2582418
X-140503825-G-C Benign/Likely benign (Nov 01, 2023)2172860
X-140503873-G-A SOX3-related disorder Likely benign (Apr 05, 2019)3047388
X-140503952-A-G Uncertain significance (Jun 10, 2022)2142051
X-140503968-T-G Likely benign (Nov 14, 2018)798184
X-140503972-GGCTGCGGCCGCA-G Likely benign (Oct 01, 2023)2661539
X-140503977-C-T not specified Uncertain significance (May 16, 2023)2546527
X-140503984-AGCTGCGGCCGCGGCGGTG-A Uncertain significance (Jul 17, 2023)2914328
X-140503993-C-T Likely benign (Jul 14, 2017)707841
X-140504001-T-G not specified Uncertain significance (Jul 13, 2021)2394342
X-140504005-G-T SOX3-related disorder Likely benign (Oct 28, 2019)3041100
X-140504032-G-A SOX3-related disorder Likely benign (Jan 07, 2022)3048175
X-140504032-G-C not specified Likely benign (May 16, 2023)2506321
X-140504053-C-T not specified Uncertain significance (Feb 16, 2023)2044067
X-140504057-C-A Uncertain significance (Apr 01, 2023)2661540
X-140504074-G-A Likely benign (Jun 27, 2018)755811
X-140504093-A-G not specified Likely benign (Apr 07, 2023)2569545
X-140504095-G-C Uncertain significance (Oct 20, 2021)2436257
X-140504105-C-T not specified Uncertain significance (Sep 27, 2022)2081454
X-140504115-C-T SOX3-related disorder Likely benign (Oct 18, 2023)2042516
X-140504120-G-C Uncertain significance (Mar 01, 2023)2661541
X-140504134-G-A Likely benign (Sep 04, 2023)2715652
X-140504166-T-A not specified Uncertain significance (Jun 21, 2022)2375186

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SOX3protein_codingprotein_codingENST00000370536 12074
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.4490.52500000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.21761530.4970.00001012786
Missense in Polyphen2379.2170.290341316
Synonymous1.115768.70.8300.00000494997
Loss of Function1.7915.540.1803.50e-7101

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcription factor required during the formation of the hypothalamo-pituitary axis. May function as a switch in neuronal development. Keeps neural cells undifferentiated by counteracting the activity of proneural proteins and suppresses neuronal differentiation. Required also within the pharyngeal epithelia for craniofacial morphogenesis. Controls a genetic switch in male development. Is necessary for initiating male sex determination by directing the development of supporting cell precursors (pre-Sertoli cells) as Sertoli rather than granulosa cells (By similarity). {ECO:0000250, ECO:0000269|PubMed:21183788}.;
Disease
DISEASE: Panhypopituitarism X-linked (PHPX) [MIM:312000]: Affected individuals have absent infundibulum, anterior pituitary hypoplasia, and ectopic posterior pituitary. {ECO:0000269|PubMed:15800844}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Mental retardation, X-linked, with isolated growth hormone deficiency (MRXGH) [MIM:300123]: A disorder characterized by the association of variable degrees of mental retardation with panhypopituitarism, variable combinations of hypothyroidism, delayed pubertal development, and short stature due to growth hormone deficiency. {ECO:0000269|PubMed:12428212}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: 46,XX sex reversal 3 (SRXX3) [MIM:300833]: A condition in which male gonads develop in a genetic female (female to male sex reversal). {ECO:0000269|PubMed:21183788}. Note=The disease is caused by mutations affecting the gene represented in this entry. Copy number variations (CNV) encompassing or in close proximity to SOX3 are responsible for XX male reversal. These variations include two duplications of approximately 123 kb and 85 kb, the former of which spans the entire SOX3 gene; a 343 kb deletion immediately upstream of SOX3 that is probably responsible of altered regulation (and not increased dosage) of SOX3; a large (approximately 6 Mb) duplication that encompasses SOX3 and at least 18 additional distally located genes. Its proximal breakpoint falls within the SOX3 regulatory region. This large rearrangement has been found in a patient with XX male reversal and a complex phenotype that also includes a scrotal hypoplasia, microcephaly, developmental delay, and growth retardation.;
Pathway
Signaling by WNT;Signal Transduction;Deactivation of the beta-catenin transactivating complex;TCF dependent signaling in response to WNT (Consensus)

Recessive Scores

pRec
0.399

Haploinsufficiency Scores

pHI
0.983
hipred
hipred_score
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.539

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Sox3
Phenotype
skeleton phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;

Zebrafish Information Network

Gene name
sox3
Affected structure
epibranchial ganglion
Phenotype tag
abnormal
Phenotype quality
decreased amount

Gene ontology

Biological process
regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;central nervous system development;sensory organ development;sex determination;hypothalamus development;pituitary gland development;cell differentiation;neuron differentiation;negative regulation of neuron differentiation;face development;negative regulation of nucleic acid-templated transcription
Cellular component
nucleus;nucleoplasm;nuclear transcription factor complex
Molecular function
RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;transcription corepressor activity